Background. Endothelial function is impaired in renal allograft recipients but the effects of antioxidant vitamin therapy on endothelial function in such patients is unknown. Methods. Thirteen renal allograft recipients were randomized to vitamin C or placebo in a double blind cross-over study design. Flow-mediated endotheliumdependent dilation and glyceryltrinitrate-induced endothelium-independent dilation of the brachial artery were assessed before and 2 h after oral administration of 2 g vitamin C or placebo. Results. Plasma vitamin C levels increased from 33.5"17.0 mmolul to 98.8"60.2 mmolul after treatment (Ps0.0001). Endothelium-dependent dilation improved (from 1.6"2.6 to 4.5"2.5%) after vitamin C administration but was unchanged after placebo (1.9"1.5 to 1.8"2.5%; Ps0.003 for vitamin C vs placebo). There was no signi®cant change in endotheliumindependent dilation in response to vitamin C. Vitamin C was also associated with a signi®cant increase in the lag time in dilute serum oxidation (Ps0.001). Conclusions. Vitamin C acutely improves¯ow-mediated, endothelium-dependent dilation and increases the resistance of lipoproteins in dilute serum to oxidation in renal transplant recipients.
Introduction
Despite the major advances in the management of patients with end-stage renal disease, these individuals still have an approximately threefold higher risk of dying from coronary heart disease (CHD) compared with age-matched healthy subjects w1x. The prevalence of established risk factors for CHD, including hyperlipidemia and hypertension, remains elevated after transplantation. Also, there is evidence of increased oxidative stress w2,3x and enhanced susceptibility of low density lipoproteins (LDLs) to oxidation w4x in renal allograft recipients. These factors have been associated with endothelial dysfunction, which is regarded as an important early event in atherogenesis. Recent studies have shown impaired endotheliumdependent vasodilation in patients with renal allografts w5,6x. However, this abnormality is apparently independent of hypercholesterolemia, hypertension, uraemia and treatment with cyclosporine w5x. The mechanism underlying endothelial dysfunction in renal allograft recipients is unclear.
Increased oxidative stress is thought to play a role in the development of endothelial dysfunction. Hypercholesterolemia, hypertension and atherosclerotic disease impair endothelial function in part by increasing vascular production of superoxide anions, which inactivate the major endothelial relaxing factor nitric oxide (NO) w7x. Oxidized LDL accumulates in vascular lesions, inhibits NO release from endothelial cells and may inactivate NO directly w8x. There is evidence that oxidation of LDL is increased in renal allograft recipients w4x. Vitamin C scavenges superoxide anions and improves endothelial dysfunction in patients with risk factors for CHD w9x and in those with proven coronary artery disease w10x. Whether oxidative mechanisms, including lipoprotein oxidation, contribute to impaired endothelium-dependent vasodilation in renal allograft recipients has not been widely studied. The purpose of the present study was therefore to determine the effect of vitamin C on endothelium-dependent vasodilation and copper ion-catalysed serum lipoprotein oxidation in renal allograft recipients.
the regional nephrology service. Inclusion criteria included stable graft function and serum creatinine -210 mmolul. Patients were at 78"59 months (range 6±188 months) post-transplantation. None of the patients was diabetic or a smoker, and none had clinical evidence of cardiovascular disease. Twelve of the 13 patients were treated with cyclosporine (whole blood trough levels 263"69 mmolul, range 181±435 mmolul); nine with prednisone and azathioprine, and three with mycophenolate. Antihypertensive treatment consisted of angiotensin converting enzyme inhibitor in 10 patients, loop diuretics in one patient, calcium antagonists in eight patients, and beta blockers in three patients. Four patients were receiving treatment for hypercholesterolemia with a statin drug. Patients' drug therapy remained unaltered during the study.
All subjects gave written informed consent and the study was approved by the regional health authority ethics committee. Studies were performed on the arm that had not previously had an arteriovenous ®stula or vascular surgery. All vasoactive medications were withheld for at least 24 h prior to the study. Patients treated with cyclosporine took their evening dose the day prior to the study, but the morning dose was withheld.
Study design
A randomized, double blind, placebo-controlled cross-over study design was used. Subjects were randomized to receive either a single oral dose of Vitamin C capsules (2 g) or similar appearing placebo. One week later the study was repeated with the alternate treatment.
After a 12 h overnight fast, subjects reported to the study centre in the early morning. Height, body weight and blood pressure in the subjects were recorded. Brachial artery reactivity was measured at baseline and 2 h after treatment. At these times, venous blood was drawn into tubes containing disodium EDTA and into a plain tube. Plasma lipids, lipoproteins, vitamin C levels and copper ion oxidation of dilute serum were measured.
Brachial artery ultrasound studies were performed in a quiet, temperature-controlled laboratory. The subjects rested in the supine position for 10 min before the study. Studies were performed using a Hewlett Packard Sonos 2000 ultrasound machine and a high resolution 7.5 MHz linear array transducer. Longitudinal scans of the right brachial artery were obtained proximal to the antecubital fossa, positioning the probe so that the best images were obtained. Operating variables of the machine were kept constant during the study. The transmit focus zone was set at the depth of the anterior wall. Images were magni®ed and gain settings optimized to optimize the vessel wall and its interface with the vessel lumen. After obtaining adequate images the arm was marked and kept in a constant position for the remainder of the study.
The method of assessing endothelium-dependent and -independent dilation was as described previously w11x. Flowmediated, endothelium-dependent dilation was assessed by measuring the arterial diameter of the brachial artery before and during reactive hyperaemia induced by de¯ation of a blood pressure cuff, previously in¯ated to 300 mmHg around the forearm for 5 min. Arterial¯ow velocity was measured using a pulsed Doppler signal at an angle of 608 in the centre of the vessel at baseline and during the ®rst 15 s of reactive hyperaemia. The artery was allowed to recover for a period of 10 min and a second baseline scan of brachial artery diameter was performed. The endothelium-independent response was assessed as the change in artery diameter after a 400 mg spray of sublingual glyceryl trinitrate (GTN).
Data analysis
Maximum arterial diameter after reactive hyperaemia was assessed 50 to 60 s after cuff de¯ation, and between 3 and 4 min after GTN administration. The ultrasound images were recorded on Super-VHS videotape for subsequent analysis. The recorded images were then digitised and stored using a Macintosh 8500 computer with built-in digitizer. Four images were digitized from each stage at end diastole, indicated by the R wave on the continuously recorded ECG. Subsequent analysis was performed using NIH Image 1.60, a public domain measurement program. The diameter of the vessel was measured by two independent investigators without knowledge of the scan sequence or treatment assignment. Arterial diameter was measured from a ®xed anatomic marker in all scans of the same patient. Measurements were taken from the anterior`m' line (mediaadventitia interface) anteriorly to the leading edge of the intima-lumen interface of the posterior wall. The four measurements for each stage were then averaged. The percentage change in the brachial artery diameter was then calculated in response to reactive hyperaemia and GTN by each observer, and the average results of the two observers recorded.
Blood¯ow at baseline and during reactive hyperaemia was calculated by multiplying the velocity±time integral of the Doppler¯ow signal by the heart rate and cross-sectional area of the blood vessel. Reactive hyperaemia was calculated as the maximal¯ow in the ®rst 15 s after cuff de¯ation divided by baseline¯ow. As the¯ow velocity was measured in the centre of the vessel, absolute¯ow may be overestimated, but relative¯ow values before and after cuff in¯ation are accurate w11x. The inter-observer variability for measurement of¯ow-mediated dilatation is 1.3% (mean difference in endothelium-dependent dilation (EDD) of 0.2%) and EDD for normal subjects is routinely 5.3"2.3% in our laboratory.
Laboratory methods
Plasma and serum were separated by low-speed centrifugation at 48C. Plasma high density lipoprotein (HDL) cholesterol was isolated in the supernatant after treatment of plasma with dextran sulphateumagnesium chloride. Cholesterol and triglycerides were measured in plasma and plasma fractions by enzymatic methods using commercial kits (Boehringer Mannheim, Germany). Plasma LDL cholesterol was calculated using the Friedewald formula. Plasma vitamin C levels were measured by a¯uorometric method w12x. The lag time in dilute serum oxidation was measured as described previously w13x.
Statistical analysis
The subject number for the study was calculated to have an 80% power at the 5% level of detecting a 2% improvement in arterial reactivity after vitamin C using a cross-over study design. Descriptive data are presented as means"SD. A twoway repeated measures analysis of variance was performed with correction for baseline values for all comparisons in the study. Spearman's rank correlation analysis was used to test for a relationship between changes in endothelial function and vitamin C concentration, and lag time in dilute serum oxidation. Statistical signi®cance was de®ned as a two-sided P value of -0.05.
Results
The 13 subjects had a mean age of 48"12 years (range 30±64 years). Blood pressure was 141"15 mmHg (systolic)u87"8 mmHg (diastolic) and was not different by treatment allocation. Body mass index for the group was 27.7"3.3 kgum 2 and mean serum creatinine was 126"40 mmolul. The effect of treatment on vitamin C, serum lag time, and lipids is shown in Table 1 . Plasma vitamin C levels increased signi®cantly 2 h after oral vitamin C administration, as did the serum lag time. Subjects had similar baseline levels of lipoprotein and triglycerides before and after vitamin C or placebo administration.
The baseline heart rate, brachial artery size, baseline vessel¯ow and hyperemic¯ow after cuff de¯ation were similar for each of the four arterial studies ( Table 2 ). There was a signi®cant increase (Ps0.003) in endothelium-dependent dilation after oral Vitamin C (1.6"2.6 vs 4.5"2.5%) compared with placebo (1.9"1.5 vs 1.8"2.5%), as shown in Figure 1 . The signi®cance of the increase in endothelium-dependent dilation after vitamin C was unchanged when variation in baseline artery size, baseline¯ow and percentage hyperemic¯ow were taken into account. The GTN-induced response was not signi®cantly (Ps0.46) different before and after vitamin C Heart rate (bpm) 67"6 6 5 "8 6 6 "10 66"9 0.43 Vessel size (mm) 4.5"0.9 4.5"0. Effect of vitamin C on EDD-and GTN-induced dilation in 13 renal allograft recipients. Subjects had brachial ultrasound examinations at baseline and 2 h after a 2 g oral dose of vitamin C or placebo. Compared with placebo, vitamin C improved endotheliumdependent dilation (Ps0.003). Vitamin C had no effect on GTNinduced dilation. Data are presented as mean"SEM.
(10.5"4.8 vs 11.4"6.6%) and placebo (9.9"5.9 vs 12.2"5.2%) administration. The increase in plasma vitamin C was correlated signi®cantly with the increase in lag time of dilute serum oxidation (rs0.60; Ps0.03).
Discussion
This randomized, double-blind, placebo-controlled cross-over trial indicates that the antioxidant vitamin C (2 g) improves brachial artery¯ow-mediated, endothelial-dependent vasodilation and does not alter endothelium-independent dilation in renal allograft recipients. Thus, increased oxidative stress may contribute to endothelial dysfunction in conduit arteries in these individuals. The factors responsible for endothelial dysfunction in renal allograft recipients are not entirely clear. Longterm immunological reaction to the graft, and renal and systemic effects of immunosuppressive therapy may increase oxidative metabolism w2x. For example, cyclosporine increases the generation of reactive oxygen species w14,15x. Hypercholesterolemia and hypertension are common in renal transplant recipients and may increase vascular oxidative stress and impair endothelial function w9x. In the present study, about half the subjects had plasma cholesterol levels in the range previously associated with endothelial dysfunction w9x, and most were receiving antihypertensive medications. However, evidence that hypertension, hypercholesterolemia and cyclosporine mediates impaired endothelium-dependent vasodilation in renal transplant recipients is limited w5,16x.
Endothelium-dependent vasodilation at baseline in the present study was lower than normal values in our laboratory and was comparable with the impaired levels reported previously in renal allograft recipients w5,6x. Acute administration of vitamin C increased ow-mediated vasodilation three-fold to levels close to those seen in healthy subjects in our laboratory. A number of mechanisms have been proposed to account for improved endothelial function induced by a high dose of vitamin C. It has been suggested that vitamin C increases endothelium-dependent NO by scavenging superoxide anions and preventing inactivation of NO, improving cellular redox status, increasing the activity of nitric oxide synthetase or inhibiting LDL oxidation. Although scavenging superoxide anions can not be discounted as a potential explanation for the effect of vitamin C on endothelial function, it has been calculated that very high, supraphysiological levels may be required to preserve endothelium-dependent NO w10x. The effect of vitamin C on cell redox status is not yet clear w10x. Nevertheless, there is evidence that vitamin C may spare intracellular levels of glutathione that can improve¯ow-mediated, endothelium-dependent dilation w17x. A recent study has reported a vitamin C-induced increase in the activity of NO synthase, which is the enzyme responsible for the formation of NO w18x. A link between resistance of isolated LDL to oxidation and endothelium-dependent vasodilation has been reported w19x. Also, oxidized LDL damages endothelial cells, inhibits release of NO from these cells and may directly inactivate NO in vitro w8x. Vitamin C in the aqueous milieu may counteract these changes by inhibiting LDL oxidation w8x. In the present study, increased plasma vitamin C levels markedly delayed the oxidation of lipoproteins in dilute serum (serum lag time) in renal transplant recipients after a dose of vitamin C. Thus, it is conceivable that increased vitamin C levels may delay lipid and lipoprotein oxidation in the artery wall and thereby improve vascular endothelial cell function. Oxidation of dilute serum may be a relevant model of lipoproteins oxidation in environments such as the arterial wall, where interstitial¯uid with its variety of antioxidants is present.
The present study has limitations. The number of subjects studied was relatively small. Thus, care should be taken in extrapolating the ®ndings to other populations of renal allograft recipients. It is possible that routine medications taken by the participants in¯u-enced our data. We attempted to minimize this effect by withholding vasoactive medications )24 h prior to each study visit. The numbers of subjects are too small and the numbers of drugs too large for reliable use of multivariate techniques to adjust data for the effect of medications. Finally, we measured endotheliumdependent dilation at only one time point following the dose of vitamin C, when plasma levels have been shown to plateau w20x.
It is possible the acute improvement in endothelial function observed in this study may be maintained during regular supplementation with vitamin C. A recent study has reported improved endotheliumdependent vasodilation maintained during long-term ascorbic acid treatment in patients with coronary artery disease w10x. The long-term effect of vitamin C supplementation on endothelial function in renal allograft recipients remains to be tested.
